Cover Image
市場調查報告書

臨床試驗用途的質譜分析市場

The Market for Mass Spectrometry in Clinical Testing Applications

出版商 Kalorama Information 商品編碼 302664
出版日期 內容資訊 英文 208 Pages
訂單完成後即時交付
價格
Back to Top
臨床試驗用途的質譜分析市場 The Market for Mass Spectrometry in Clinical Testing Applications
出版日期: 2017年01月03日 內容資訊: 英文 208 Pages
簡介

本報告提供臨床試驗用途的質譜分析市場相關資料,以全球質譜分析產品 (設備·消耗品) 市場為焦點加以分析,提供產品收益 (設備,試劑/消耗品) 、業務收益,研究 vs. 臨床產品市場,地區市場,各企業市場佔有率,及質譜儀的各類型市場預測,再加上主要企業簡介,為您概述為以下內容。

第1章 摘要整理

第2章 簡介

第3章 質譜分析概要

  • 質譜分析的種類:概要
  • 質譜分析平台·相關產品的交易企業
  • 臨床實驗室的質譜分析平台

第4章 研究·臨床實驗室的質譜分析

  • 質譜分析的研究用途
  • 臨床實驗室的質譜分析
  • 臨床實驗室的質譜分析的初期應用
  • 腫瘤
  • 感染疾病
  • 質譜分析的其他臨床應用
  • 質譜分析的其他應用

第5章 契約:質譜分析企業

  • 投資·融資契約
  • M&A
  • 其他公司間協議·合作
  • 質譜分析企業2公司間的合作/協定
  • 診斷企業及/或是臨床實驗室的合作/協定
  • 與醫藥品·生物醫藥品企業的合作/協定
  • 與其他企業的合作/協定
  • 與大學,非營利研究機關及政府的合作以及其他的協定

第6章 臨床實驗室的質譜分析:市場成長的促進要素·課題

  • 質譜分析技術·平台
  • 對質譜分析型化驗分析前,分析,分析後零組件整合的需求:質譜分析平台的進步
  • 質譜分析 vs. 免疫學的檢測法:優點與缺點
  • 質譜分析臨床市場促進要素
  • 質譜分析臨床應用數的增加
  • 腫瘤市場促進要素
  • 新生兒篩檢及遺傳分析市場促進要素
  • 感染疾病市場促進要素
  • 臨床質譜分析市場及其他市場區隔的市場成長的促進要素
  • 競爭
  • 其他市場上質譜分析的潛在影響
  • 現在,大部分的質譜分析臨床化驗藥事未核准檢驗 (LDT)
  • 質譜分析型體外診斷 (IVD) 實驗的法規
  • 未來展望

第7章 質譜分析市場分析

  • 質譜分析市場概要
  • 研究 vs. 臨床質量
  • 質譜分析市場:地區分佈
  • 質譜分析市場:市場佔有率,各企業
  • 質譜分析市場 (銷售到臨床實驗室的產品) :作為對象的臨床類別
  • 質譜分析市場:質譜儀類別

第8章 企業簡介:質譜分析企業

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI15217025

Mass spectrometry has been primarily used in research applications, with early applications focused on small molecules. However, development of soft-ionization techniques such as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) has made it possible to study larger molecules such as proteins, peptides, DNA, and other large molecules without extensive fragmentation, opening up a whole new world of opportunities as mass spectrometry now moves into the clinical laboratory. The Market for Mass Spectrometry in Clinical Testing Applications focuses on the worldwide market for mass spectrometry products - instruments and consumables - and includes the following information:

  • Mass Spectrometry Market, Worldwide, 2016 and 2021 [Products and Services Provided by Mass Spectrometry Companies] (Total mass spectrometry market; Product Revenue: Instruments, Reagents/Consumables, Total product revenue; Service revenue)
  • Mass Spectrometry Market (Products) - Research vs. Clinical, 2016 and 2021
  • Mass Spectrometry Product Market by Geographical Region, Worldwide, 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market)
  • Mass Spectrometry Market Share by Company, 2016 (%)
  • Clinical Mass Spectrometry Product Market by Intended Clinical Category, 2016 (%) (Microbial Identification, Small molecule applications)
  • Mass Spectrometry Market - By Type of Mass Spectrometer (%)

The report looks as well at the market drivers and challenges for mass spectrometry in the clinical lab, including the advantages and disadvantages of mass spectrometry and current trends in the mass spectrometry market.

The clinical diagnostic applications of mass spectrometry are expanding. Mass spectrometry has already had a disruptive impact on microbial identification. Mass spectrometry is now being applied to a growing number of oncology applications, and there is a growing awareness of the importance of both genomic and proteomic information for many oncology diagnostic applications. Mass spectrometry has the potential to be applied to other diagnostic applications as well, as discussed in this report.

With this market potential, many companies are making deals in this promising area. The report discusses selected investment and financing agreements in mass spectrometry companies, selected acquisitions, selected agreements between mass spectrometry companies, selected agreements between mass spectrometry platform/reagent companies and mass spectrometry software companies, selected company agreements between mass spectrometry companies and diagnostic companies or clinical laboratories, selected agreements among mass spectrometry companies and pharmaceutical or biopharmaceutical companies (includes contract research organizations providing services to pharma companies), and selected mass spectrometry company agreements with academic or other non-profit organizations.

The report includes company profiles of the players in the mass spectrometry market:

  • 908 Devices Inc.
  • Abbott Laboratories
  • Advion, Inc.
  • Agena Bioscience, Inc.
  • Agilent Technologies Inc.
  • Andromas SAS
  • Applied Proteomics, Inc.
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • BGI
  • Biocrates Life Sciences AG
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Caprion Biosciences, Inc.
  • caprotec bioanalytics GmbH
  • Danaher Corporation
  • Fluidigm Corporation
  • ImaBiotech
  • Integrated Diagnostics, Inc.
  • JEOL Ltd.
  • KineMed, Inc.
  • Microsaic Systems plc
  • mosaiques diagnostics and therapeutics AG and DiaPat GmbH
  • PerkinElmer, Inc.
  • Proteome Sciences plc
  • SCIEX
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

Table of Contents

Chapter 1: Executive Summary

  • Overview
  • Scope and Methodology
  • Market Overview
  • Future Prospects in the Mass Spectrometry Market

Chapter 2: Introduction

  • Brief History of Mass Spectrometry
  • Point-of-View

Chapter 3: Mass Spectrometry Overview

  • Types of Mass Spectrometry - Overview
  • Companies Marketing Mass Spectrometry Platforms and Related Products
  • Mass Spectrometry Platforms in the Clinical Laboratory

Chapter 4: Mass Spectrometry in Research and the Clinical Laboratory

  • Research Applications of Mass Spectrometry
  • Mass Spectrometry in the Clinical Laboratory
  • Early Applications of Mass Spectrometry in the Clinical Laboratory
  • Oncology
  • Infectious Disease
  • Other Clinical Applications of Mass Spectrometry
  • Other Applications of Mass Spectrometry

Chapter 5: Deals - Mass Spectrometry Companies

  • Investments and Financing Agreements
  • Mergers and Acquisitions
  • Other Corporate Agreements and Collaborations
  • Collaborations/Agreements Between Two Mass Spectrometry Companies
  • Collaborations/Agreements with Diagnostic Companies and/or Clinical Laboratories
  • Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
  • Other Company Collaborations/Agreements
  • Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government

Chapter 6: Mass Spectrometry in the Clinical Laboratory - Market Drivers and Challenges

  • Mass Spectrometry Technology and Platforms
  • Need for Integration of Pre-analytical, Analytical, and Post-analytical Components of Mass Spectrometry Based Assays; Advances in Mass Spectrometry Platforms
  • Mass Spectrometry vs. Immunoassays - Advantages and Disadvantages
  • Mass Spectrometry Clinical Market Drivers
  • Increasing Number of Clinical Applications for Mass Spectrometry
  • Oncology Market Drivers
  • Newborn Screening and Genetic Analysis Market Drivers
  • Infectious Disease Market Drivers
  • Market Drivers for Other Segments of the Clinical Mass Spectrometry Market
  • Competition
  • Potential Impact of Mass Spectrometry on Other Markets
  • Most Mass Spectrometry Clinical Assays Today are Laboratory Developed Tests (LDTs)
  • Regulation of Mass Spectrometry-Based In Vitro Diagnostic (IVD) Tests
  • Future Prospects

Chapter 7: Mass Spectrometry Market Analysis

  • Mass Spectrometry Market Overview
  • Research versus Clinical Mass Spectrometry Market
  • Mass Spectrometry Market - Geographical Distribution
  • Mass Spectrometry Market - Market Shares by Company
  • Mass Spectrometry Market (Products Sold to Clinical Laboratories) - By Intended Clinical Category, 2016
  • Mass Spectrometry Market - By Type of Mass Spectrometer

Chapter 8: Company Profiles - Mass Spectrometry Companies

  • 908 Devices Inc.
  • Abbott Laboratories
  • Recent Revenue History
  • Company Overview - With a Focus on Sequencing
  • Advion, Inc.
  • Agena Bioscience, Inc.
  • Applying MassARRAY System to Clinical Diagnostics
  • Agilent Technologies Inc.
  • Recent Revenue History
  • Company Overview
  • Andromas SAS
  • Applied Proteomics, Inc.
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Revenue History
  • Company Overview
  • BGI
  • Biocrates Life Sciences AG
  • Biodesix, Inc.
  • Biodesix Lung Reflex™
  • Research Activities
  • Investors/Financings
  • Other Agreements
  • Biognosys AG
  • bioMérieux SA
  • Recent Revenue History
  • Company Overview
  • Traditional Microbiology
  • Mass Spectrometry for Clinical Laboratories
  • Bio-Rad Laboratories, Inc.
  • Recent Revenue History
  • Company Overview
  • Bruker Corporation
  • Recent Revenue History
  • Company Overview
  • Caprion Biosciences, Inc.
  • caprotec bioanalytics GmbH
  • Danaher Corporation
  • Recent Revenue History
  • Company Overview
  • Fluidigm Corporation
  • Recent Revenue History
  • Company Overview
  • ImaBiotech
  • Integrated Diagnostics, Inc.
  • Financing History
  • Selected Deals
  • Indi Molecular
  • JEOL Ltd.
  • Recent Revenue History
  • Company Overview
  • KineMed, Inc.
  • Microsaic Systems plc
  • Recent Revenue History
  • Company Overview
  • mosaiques diagnostics and therapeutics AG and DiaPat GmbH
  • PerkinElmer, Inc.
  • Recent Revenue History
  • Company Overview
  • Proteome Sciences plc
  • Recent Revenue History
  • Company Overview
  • SCIEX
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Recent Revenue History
  • Company Overview
  • Thermo Fisher Scientific, Inc.
  • Recent Revenue History
  • Company Overview
  • Waters Corporation
  • Recent Revenue History
  • Company Overview

List of Exhibits

1: Executive Summary

  • Table 1-1: Worldwide Mass Spectrometry Product Revenues (Instruments and Consumables), 2016 and 2021

3: Mass Spectrometry Overview

  • Table 3-1: Selected Companies Developing/Marketing Mass Spectrometers
  • Table 3-2: Selected Companies Marketing Tools/Reagents/Kits/Consumables for Mass Spectrometry
  • Table 3-3: Selected Companies Marketing Software for Mass Spectrometry
  • Table 3-4: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]

4: Mass Spectrometry in Research and the Clinical Laboratory

  • Table 4-1: Selected Mass Spectrometry Based Oncology Tests
  • Table 4-2: Selected Mass Spectrometry Based Infectious Disease Tests for Microorganism Identification and Antibiotic Susceptibility
  • Table 4-3: Selected Other Mass Spectrometry Based Clinical Tests

5: Deals - Mass Spectrometry Companies

  • Table 5-1: Selected Investment and Financing Agreements in Mass Spectrometry Companies
  • Table 5-2: Selected Acquisitions of Mass Spectrometry Companies
  • Table 5-3: Selected Company Agreements Between Two Mass Spectrometry Companies
  • Table 5-4: Selected Company Agreements Between Mass Spectrometry Platform/Reagent Companies and Mass Spectrometry Software Companies
  • Table 5-5: Selected Company Agreements Between Mass Spectrometry Companies and Diagnostic Companies or Clinical Laboratory
  • Table 5-6: Selected Agreements Mass Spectrometry Companies and Pharmaceutical or Biopharmaceutical Companies [Includes Contract Research Organizations Providing Services to Pharma Companies]
  • Table 5-7: Selected Other Mass Spectrometry Company Agreements
  • Table 5-8: Selected Mass Spectrometry Company Agreements with Academic or Other Non-Profit Organizations

6: Mass Spectrometry in the Clinical Laboratory - Market Drivers and Challenges

  • Table 6-1: Advantages and Disadvantages of Mass Spectrometry
  • Table 6-2: Trends in the Mass Spectrometry Market

7: Mass Spectrometry Market Analysis

  • Table 7-1: Mass Spectrometry Market, Worldwide, 2016 and 2021 [Products and Services Provided by Mass Spectrometry Companies] (Total mass spectrometry market; Product Revenue: Instruments, Reagents/Consumables, Total product revenue; Service revenue)
  • Table 7-2: Mass Spectrometry Market (Products) - Research vs. Clinical, 2016 and 2021
  • Table 7-3: Mass Spectrometry Product Market by Geographical Region, Worldwide, 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market)
  • Table 7-4: Mass Spectrometry Market Share by Company, 2016 (%)
  • Table 7-5: Clinical Mass Spectrometry Product Market by Intended Clinical Category, 2016 (%) (Microbial Identification, Small molecule applications)
  • Table 7-6: Mass Spectrometry Market - By Type of Mass Spectrometer (%)

8: Company Profiles - Mass Spectrometry Companies

  • Table 8-1: Abbott Revenues (2013, 2014, 2015, 3 quarters of 2016)
  • Table 8-2: Agilent Technologies Revenues (2013, 2014, 2015)
  • Table 8-3: bioMérieux Revenues (2013, 2014, 2015, 3 quarters of 2016)
  • Table 8-4: Bio-Rad Laboratories Revenues (2013, 2014, 2015, 3 quarters of 2016)
  • Table 8-5: Bruker Corporation Revenues (2013, 2014, 2015, 3 quarters of 2016)
  • Table 8-6: Danaher Revenues (2013, 2014, 2015, 3 quarters of 2016)
  • Table 8-7: Fluidigm Revenues (2013, 2014, 2015, 3 quarters of 2016)
  • Table 8-8: Microsaic Systems Revenues (2013, 2014, 2015)
  • Table 8-9: PerkinElmer Revenues (2015 and 2016)
  • Table 8-10: Proteome Sciences Revenues (2013, 2014, 2015)
  • Table 8-11: Shimadzu Revenues (Years Ending March 31, 2016 and 2015)
  • Table 8-12: Thermo Fisher Scientific Revenues (2013, 2014, 2015)
  • Table 8-13: Waters Corporation Revenues (2013, 2014, 2015)
Back to Top